NM_173551.5:c.658G>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_173551.5(ANKS6):​c.658G>A​(p.Ala220Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,607,358 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A220P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 10 hom. )

Consequence

ANKS6
NM_173551.5 missense

Scores

19

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.00900

Publications

8 publications found
Variant links:
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
  • nephronophthisis 16
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003323108).
BP6
Variant 9-98790308-C-T is Benign according to our data. Variant chr9-98790308-C-T is described in ClinVar as Benign. ClinVar VariationId is 474454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKS6NM_173551.5 linkc.658G>A p.Ala220Thr missense_variant Exon 2 of 15 ENST00000353234.5 NP_775822.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKS6ENST00000353234.5 linkc.658G>A p.Ala220Thr missense_variant Exon 2 of 15 1 NM_173551.5 ENSP00000297837.6

Frequencies

GnomAD3 genomes
AF:
0.00269
AC:
409
AN:
152218
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00528
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00366
Gnomad ASJ
AF:
0.0184
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000867
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00197
AC:
481
AN:
244436
AF XY:
0.00189
show subpopulations
Gnomad AFR exome
AF:
0.00493
Gnomad AMR exome
AF:
0.00276
Gnomad ASJ exome
AF:
0.0165
Gnomad EAS exome
AF:
0.000112
Gnomad FIN exome
AF:
0.0000496
Gnomad NFE exome
AF:
0.00106
Gnomad OTH exome
AF:
0.00417
GnomAD4 exome
AF:
0.00134
AC:
1944
AN:
1455020
Hom.:
10
Cov.:
31
AF XY:
0.00130
AC XY:
940
AN XY:
722866
show subpopulations
African (AFR)
AF:
0.00647
AC:
216
AN:
33388
American (AMR)
AF:
0.00282
AC:
126
AN:
44624
Ashkenazi Jewish (ASJ)
AF:
0.0152
AC:
397
AN:
26070
East Asian (EAS)
AF:
0.0000759
AC:
3
AN:
39506
South Asian (SAS)
AF:
0.0000813
AC:
7
AN:
86140
European-Finnish (FIN)
AF:
0.0000389
AC:
2
AN:
51408
Middle Eastern (MID)
AF:
0.00556
AC:
32
AN:
5756
European-Non Finnish (NFE)
AF:
0.000864
AC:
957
AN:
1108052
Other (OTH)
AF:
0.00340
AC:
204
AN:
60076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
134
268
403
537
671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00269
AC:
410
AN:
152338
Hom.:
1
Cov.:
32
AF XY:
0.00274
AC XY:
204
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00529
AC:
220
AN:
41578
American (AMR)
AF:
0.00366
AC:
56
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0184
AC:
64
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000867
AC:
59
AN:
68030
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00202
Hom.:
1
Bravo
AF:
0.00323
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00368
AC:
15
ESP6500EA
AF:
0.00120
AC:
10
ExAC
AF:
0.00159
AC:
192
EpiCase
AF:
0.00185
EpiControl
AF:
0.00190

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Oct 02, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephronophthisis 16 Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.21
DANN
Benign
0.82
DEOGEN2
Benign
0.0069
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.41
T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.0033
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.0090
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.47
N
REVEL
Benign
0.014
Sift
Benign
0.71
T
Sift4G
Benign
0.87
T
Polyphen
0.0010
B
Vest4
0.11
MVP
0.28
MPC
0.098
ClinPred
0.00053
T
GERP RS
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.026
gMVP
0.21
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200419394; hg19: chr9-101552590; API